Joint Formulary & PAD

Zolpidem - Primary insomnia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
CD
NICE
SPC
Restrictions / Comments :
Important

For the short-term treatment of insomnia in adults in situations where the insomnia is debilitating or is causing severe distress for the patient.

 

Status 2

See narrative
Formulations :
  • Oro-dispersible tablets
Associated Icons :
NFD2
SPC
Restrictions / Comments :
Important

Orodispersible tablets have not been agreed for addition to formulary. Please contact pharmacy for advice.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Zolpidem
Indication :
Primary insomnia
Group Name :
Keywords :
hypnotics, z-drugs
Brand Names Include :
Stilnoct
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Committee Recommendations (1)

This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status

Other Indications

Below are listed other indications that Zolpidem is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Primary insomnia.